Furthermore, distinct independent associations of FABP4 concentration with adiposity, renal dysfunction and hypertriglyceridemia and a distinct independent association of FABP5 level with a low HDL level were found in type 2 diabetic patients at high risks for cardiovascular disease who were receiving statin therapy. Here, FABP4 is linked to hypertriglyceridemia.